INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,291,090 | +9.4% | 154,269 | 0.0% | 0.25% | +12.3% |
| Q1 2023 | $5,749,606 | +6.8% | 154,269 | 0.0% | 0.22% | +7.9% |
| Q4 2022 | $5,382,445 | -37.7% | 154,269 | 0.0% | 0.20% | -42.5% |
| Q3 2022 | $8,633,000 | +186.7% | 154,269 | +165.2% | 0.35% | +199.2% |
| Q2 2022 | $3,011,000 | -28.8% | 58,180 | 0.0% | 0.12% | -20.3% |
| Q1 2022 | $4,228,000 | -38.5% | 58,180 | 0.0% | 0.15% | -33.0% |
| Q4 2021 | $6,879,000 | -11.9% | 58,180 | 0.0% | 0.22% | -12.0% |
| Q3 2021 | $7,805,000 | -17.1% | 58,180 | 0.0% | 0.25% | -18.0% |
| Q2 2021 | $9,420,000 | +120.7% | 58,180 | +9.4% | 0.31% | +108.2% |
| Q1 2021 | $4,268,000 | +268.9% | 53,180 | -3.4% | 0.15% | +234.1% |
| Q2 2020 | $1,157,000 | +71.9% | 55,050 | 0.0% | 0.04% | +46.7% |
| Q1 2020 | $673,000 | -16.7% | 55,050 | 0.0% | 0.03% | -3.2% |
| Q4 2019 | $808,000 | +9.9% | 55,050 | 0.0% | 0.03% | -3.1% |
| Q3 2019 | $735,000 | -70.1% | 55,050 | -63.4% | 0.03% | -68.0% |
| Q2 2019 | $2,460,000 | -4.2% | 150,290 | 0.0% | 0.10% | -3.8% |
| Q1 2019 | $2,567,000 | +25.2% | 150,290 | 0.0% | 0.10% | +18.2% |
| Q4 2018 | $2,051,000 | +4.4% | 150,290 | +118.9% | 0.09% | +23.9% |
| Q3 2018 | $1,965,000 | -57.1% | 68,671 | -59.0% | 0.07% | -59.2% |
| Q2 2018 | $4,580,000 | +29.7% | 167,381 | 0.0% | 0.17% | +27.0% |
| Q1 2018 | $3,530,000 | +687.9% | 167,381 | +497.8% | 0.14% | +705.9% |
| Q2 2017 | $448,000 | -55.7% | 28,000 | -61.0% | 0.02% | -56.4% |
| Q1 2017 | $1,012,000 | +7.4% | 71,842 | 0.0% | 0.04% | -2.5% |
| Q4 2016 | $942,000 | -23.0% | 71,842 | 0.0% | 0.04% | -14.9% |
| Q3 2016 | $1,223,000 | -34.0% | 71,842 | -17.3% | 0.05% | -38.2% |
| Q2 2016 | $1,854,000 | – | 86,842 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |